
GlucoTrack, Inc.
GCTKNASDAQHealthcare● Active
$0.55
$-0.06(-9.11%)
Market Cap$312555
P/E Ratio—
52W High$15.9
52W Low$0.431
GlucoTrack, Inc.(GCTK)· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。
FMP · GCTK · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Cost of Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Gross Profit | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Gross Margin %(computed) | — | — | — | — | — |
| Operating Expenses | |||||
| R&D Expenses | $0.01B | $0.01B | $0.00B | $0.00B | $0.00B |
| G&A Expenses | $0.01B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Operating Expenses | $0.02B | $0.01B | $0.01B | $0.00B | $0.00B |
| Operating Income | ($0.02B) | ($0.01B) | ($0.01B) | ($0.00B) | ($0.00B) |
| Operating Margin %(computed) | — | — | — | — | — |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | ($0.02B) | ($0.02B) | ($0.01B) | ($0.00B) | ($0.00B) |
| Income Tax Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Income | ($0.02B) | ($0.02B) | ($0.01B) | ($0.00B) | ($0.00B) |
| Net Margin %(computed) | — | — | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-21.56 | $60.76 | $-38.30 | $-28.66 | $-26.32 |
| Wtd Avg Shares | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B |
| EBITDA | ($0.02B) | ($0.01B) | ($0.01B) | ($0.00B) | ($0.00B) |
| EBITDA Margin %(computed) | — | — | — | — | — |
数据来源:Financial Modeling Prep · 最后更新:2026-06-08 · USD · B
深入了解GlucoTrack, Inc.
关于GlucoTrack, Inc.(GCTK)损益表
GlucoTrack, Inc.(GCTK)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,GCTK实现营收$0.00B,毛利润$0.00B(毛利率—),净利润($0.02B)(净利率—)。
常见问题
GCTK · 4 问GlucoTrack, Inc.(GCTK)2025财年营收为$0.00B,同比down—%。
GCTK revenueGCTK salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08